Explore

Rapid Read Rapid Read
Research Identifies Biological Age as Key Factor in Dementia Risk Prediction

Research Identifies Biological Age as Key Factor in Dementia Risk Prediction

Recent research from the UK highlights the significance of biological age in predicting dementia risk, suggesting that it may be a more accurate indicator than chronological age. The study, led by Julian Mutz of King’s College London, analyzed data from over 220,000 UK residents, focusing on metabolites in their blood and their incidence of dementia. The findings indicate that individuals with a higher biological age compared to their chronological age are more likely to develop dementia. This research underscores the potential of using biological aging data to identify at-risk individuals before clinical symptoms appear. The study also found that those with older biological ages and specific genetic markers, such as two copies of APOE4, are significantly more likely to develop dementia.
Trendline Trendline
Study Finds Engaging with Arts and Culture Can Slow Biological Aging

Study Finds Engaging with Arts and Culture Can Slow Biological Aging

Study Finds Engaging with Arts and Culture Can Slow Biological Aging
Trendline Trendline
Study Finds Arts Engagement Can Slow Biological Aging Comparable to Exercise

Study Finds Arts Engagement Can Slow Biological Aging Comparable to Exercise

Study Finds Arts Engagement Can Slow Biological Aging Comparable to Exercise
Rapid Read Rapid Read
Osel Inc. and March of Dimes Launch Phase 2b Trial for Preterm Birth Prevention Therapy

Osel Inc. and March of Dimes Launch Phase 2b Trial for Preterm Birth Prevention Therapy

Osel Inc., in collaboration with the March of Dimes and Imperial College London, has announced the launch of a Phase 2b clinical trial to evaluate LACTIN-V, a microbiome-based therapy aimed at preventing preterm birth. The trial, known as FLIP-2, will assess the efficacy and safety of LACTIN-V in pregnant women at high risk of preterm birth. LACTIN-V contains Lactobacillus crispatus, a beneficial bacterium designed to restore a healthy vaginal microbiome, which is believed to be a significant factor in preventing preterm birth. The trial will enroll 360 participants across four maternity units in the UK.
Discover daily Discover daily
The Song That Captured 1960s Youth Rebellion

The Song That Captured 1960s Youth Rebellion

"(I Can't Get No) Satisfaction" by the Rolling Stones is more than just a song; it is a cultural phenomenon that has left an indelible mark on musi...
Rapid Read Rapid Read
Roche Receives CE Mark for Alzheimer's Blood Test, Aiming to Accelerate Diagnosis

Roche Receives CE Mark for Alzheimer's Blood Test, Aiming to Accelerate Diagnosis

Roche has announced the receipt of a CE Mark for its Elecsys® pTau217 blood test, developed in collaboration with Eli Lilly and Company. This test is designed to detect phosphorylated Tau (pTau) 217 protein, a key indicator of amyloid pathology associated with Alzheimer's disease. The Elecsys® pTau217 test offers a minimally invasive alternative to traditional diagnostic methods like PET-CT scans and cerebrospinal fluid assessments, which are often costly and less accessible. The test aims to provide a faster and more convenient diagnosis for Alzheimer's, potentially reducing the average 3.5-year delay in diagnosing dementia. This development is significant as it could help address the issue of underdiagnosis, with an estimated 75% of dementia cases currently undiagnosed.
Trendline Trendline
Roche's New Alzheimer's Blood Test Receives CE Mark, Promises Faster Diagnosis

Roche's New Alzheimer's Blood Test Receives CE Mark, Promises Faster Diagnosis

Roche's New Alzheimer's Blood Test Receives CE Mark, Promises Faster Diagnosis
Rapid Read Rapid Read
Enterprise Therapeutics' Phase 2 Trial for Cystic Fibrosis Drug ETD001 Shows Promising Results

Enterprise Therapeutics' Phase 2 Trial for Cystic Fibrosis Drug ETD001 Shows Promising Results

Enterprise Therapeutics Ltd has announced successful results from its Phase 2 clinical trial for ETD001, an investigational inhaled epithelial sodium channel (ENaC) blocker designed to treat cystic fibrosis (CF). The trial demonstrated a statistically significant improvement in lung function for patients who do not benefit from CFTR modulators. Conducted across sites in the UK, Germany, France, and Italy, the trial involved participants with the highest unmet medical need. The results showed a 3.4% improvement in percent predicted forced expiratory volume in 1 second (ppFEV1) compared to placebo, with ETD001 being well-tolerated. The trial was divided into two parts, assessing safety and efficacy over a 28-day period. Enterprise plans to advance to longer duration Phase 2b trials and explore ETD001's efficacy alongside CFTR modulators.
Trendline Trendline
SCS Annual Conference Highlights Cosmetic Science Innovations in Liverpool

SCS Annual Conference Highlights Cosmetic Science Innovations in Liverpool

SCS Annual Conference Highlights Cosmetic Science Innovations in Liverpool
Reuters Reuters
Morning Bid: Ceasefire on life support

Morning Bid: Ceasefire on life support

By Mike Dolan May 12 (Reuters) - What matters in U.S. and global markets today By Mike Dolan, Editor-At-Large, Finance and Markets With the month-old Iran war ceasefire now on “life support”, according to U.S.
Rapid Read Rapid Read
Port of Dover Hosts Four Cruise Ships Simultaneously, Marking a Milestone

Port of Dover Hosts Four Cruise Ships Simultaneously, Marking a Milestone

The Port of Dover in the UK achieved a significant milestone by hosting four cruise ships simultaneously for the first time. On May 8, 2026, the Celebrity Eclipse, Viking Sky, HX Expeditions’ MS Fram, and Ponant’s Le Bellot all docked at the port, marking the busiest cruise day in its history. This event underscores Dover's growing status as a premier cruise hub in the UK, capable of handling both turnaround and transit calls. The achievement is attributed to months of planning and the efforts of the port's operations team. The event coincided with the Cruise Lines International Association (CLIA) hosting a ship visit to the MS Fram for about 100 travel agents as part of its annual Expedition Summit.
Reuters Reuters
European equities fall as fragile Mideast ceasefire dents risk sentiment

European equities fall as fragile Mideast ceasefire dents risk sentiment

By Twesha Dikshit May 12 (Reuters) - European shares fell on Tuesday as fading hopes of a U.S.-Iran peace deal pushed oil prices higher and kept investors on edge. U.S.